Sign in
4

Changes in Ownership

OCULAR THERAPEUTIX, INC Filed Acc 0001104659-26-019802

Chief Strategy Officer sold 1,759 shares at $8.28 ($14,565)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Nayak Sanjay Chief Strategy Officer 2026-02-23 Sale 10b5-1 −1,759 $8.28 $14,565 330,653 D: show line 1 in the form
Open-market sales · 1,759 sh · avg $8.28 · $14,565
Loading xslF345X05/tm267255-1_4seq1.xml…